首页> 外文期刊>Critical reviews in oncology/hematology >One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?
【24h】

One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?

机译:领先一步:MiRNA-34在结肠癌 - 未来的诊断和治疗工具中?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The discovery that microRNAs (miRNAs) - short, non-coding RNA molecules which regulate gene expression are implicated in many types of cancer has revolutionised cancer research, giving hope for a new perspective in diagnostics and treatment. Dysregulation of miRNAs occurs in various malignancies, including colorectal cancer (CRC). CRC is one of the leading causes of cancer-related death and in most countries its incidence is still rising. Among several miRNAs which have been linked to CRC, miR-34 has attracted particular attention. This miRNA is involved in the regulation of cell cycle and apoptosis through multiple signaling pathways such as p53, Ra and Wnt signaling. Understanding its role in CRC may facilitate its future use as a diagnostic tool and therapeutic target.
机译:调节基因表达的MicroRNA(miRNA) - 短,非编码RNA分子在许多类型的癌症中牵连的癌症研究,为诊断和治疗提供了新的视角。 miRNA的失调发生在各种恶性肿瘤中,包括结肠直肠癌(CRC)。 CRC是癌症相关死亡的主要原因之一,并且在大多数国家的发病率仍在上升。 在与CRC相关联的几个miRNA中,MIR-34引起了特别的关注。 该miRNA参与细胞周期和细胞凋亡的调节,通过多信号传导途径,例如P53,RA和WNT信号传导。 了解其在CRC中的作用可以促进其未来用作诊断工具和治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号